Kyntra Bio's total assets for Q2 2026 were $101.08M, a decrease of -7.80% from the previous quarter. MX:KYNB total liabilities were $109.22M for the fiscal quarter, a -22.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.